SKI Market

A+| A| A-|

Indian Indices

Sensex

77,043.82 -259.81
( -0.34%)

Global Indices

Nasdaq

49,198.35 -53.37
(-0.11%)

Dow Jones

7,195.79 9.71
(0.14%)

Hang Seng

59,839.06 -698.30
(-1.15%)

Nikkei 225

10,331.11 -47.97
(-0.46%)

Forex

USD-INR

93.91 -0.14
(-0.15%)

EUR-INR

110.02 0.03
(0.03%)

GBP-INR

127.00 0.16
(0.13%)

JPY-INR

0.59 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

95.32

415996.7

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.92

Back

incredible industries ltd

Everest Organics standalone net profit rises 56.76% in the September 2025 quarter

Nov 13,2025

Net profit of Everest Organics rose 56.76% to Rs 1.16 crore in the quarter ended September 2025 as against Rs 0.74 crore during the previous quarter ended September 2024. Sales rose 15.78% to Rs 51.00 crore in the quarter ended September 2025 as against Rs 44.05 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	51.00	44.05	16
OPM %	10.08	7.79	-
PBDT	4.20	2.22	89
PBT	2.68	0.75	257
NP	1.16	0.74	57

77,043.82 -259.81 ( -0.34%)

49,198.35 -53.37 (-0.11%)

7,195.79 9.71 (0.14%)

59,839.06 -698.30 (-1.15%)

10,331.11 -47.97 (-0.46%)

93.91 -0.14 (-0.15%)

110.02 0.03 (0.03%)

127.00 0.16 (0.13%)

0.59 0.00 (-0.03%)